Cargando…

Immune Mechanisms Involved in Schistosoma mansoni-Cathepsin B Vaccine Induced Protection in Mice

A vaccine against schistosomiasis would contribute to a long-lasting decrease in disease spectrum and transmission. Our previous protection studies in mice using Schistosoma mansoni Cathepsin B (Sm-Cathepsin B) resulted in 59 and 60% worm burden reduction with CpG oligodeoxynucleotides and Montanide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ricciardi, Alessandra, Zelt, Nicholas H., Visitsunthorn, Kittipos, Dalton, John P., Ndao, Momar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068236/ https://www.ncbi.nlm.nih.gov/pubmed/30090103 http://dx.doi.org/10.3389/fimmu.2018.01710

Ejemplares similares

A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis
por: Ricciardi, Alessandra, et al.
Publicado: (2016)

Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model
por: Perera, Dilhan J., et al.
Publicado: (2020)

Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model
por: Hassan, Adam S., et al.
Publicado: (2019)

Correction: Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model
por: Hassan, Adam S., et al.
Publicado: (2021)

Salmonella Typhimurium expressing chromosomally integrated Schistosoma mansoni Cathepsin B protects against schistosomiasis in mice
por: Hassan, Adam S., et al.
Publicado: (2023)

A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
por: Perera, Dilhan J., et al.
Publicado: (2022)

Identification of Candidate Serum Biomarkers for Schistosoma mansoni Infected Mice Using Multiple Proteomic Platforms
por: Kardoush, Manal I., et al.
Publicado: (2016)

Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice
por: Morais, Suellen B., et al.
Publicado: (2018)

Promising Technologies in the Field of Helminth Vaccines
por: Perera, Dilhan J., et al.
Publicado: (2021)

Dynamics of host immune response development during Schistosoma mansoni infection
por: Costain, Alice H., et al.
Publicado: (2022)

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
por: Milligan, John N., et al.
Publicado: (2011)

Vitamin B6 Acquisition and Metabolism in Schistosoma mansoni
por: Da’dara, Akram A., et al.
Publicado: (2021)

Praziquantel Treatment of Schistosoma mansoni Infected Mice Renders Them Less Susceptible to Reinfection
por: Nono, Justin Komguep, et al.
Publicado: (2021)

A Meta-Analysis of Experimental Studies of Attenuated Schistosoma mansoni Vaccines in the Mouse Model
por: Fukushige, Mizuho, et al.
Publicado: (2015)

Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development
por: Figueiredo, Barbara Castro-Pimentel, et al.
Publicado: (2015)

Schistosome Syntenin Partially Protects Vaccinated Mice against Schistosoma mansoni Infection
por: Figueiredo, Barbara C., et al.
Publicado: (2014)

A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against Schistosoma mansoni Reinfection in Mice
por: Alves, Clarice Carvalho, et al.
Publicado: (2018)

Corrigendum: Dynamics of host immune response development during Schistosoma mansoni infection
por: Costain, Alice H., et al.
Publicado: (2023)

Schistosoma mansoni Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype
por: Cortes-Selva, Diana, et al.
Publicado: (2018)

Unisexual infection with Schistosoma mansoni in mice has the potential to boost the immune response against eggs after challenge infection
por: Reinholdt, Cindy, et al.
Publicado: (2023)

Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders
por: Cleenewerk, L., et al.
Publicado: (2020)

Host-Specific Serum Factors Control the Development and Survival of Schistosoma mansoni
por: Anisuzzaman,, et al.
Publicado: (2021)

Smp38 MAP Kinase Regulation in Schistosoma mansoni: Roles in Survival, Oviposition, and Protection Against Oxidative Stress
por: Avelar, Lívia das Graças Amaral, et al.
Publicado: (2019)

Genetic/Environmental Contributions and Immune Dysregulation in Children with Atopic Dermatitis
por: Chong, Albert C, et al.
Publicado: (2022)

The Diagnosis of Human Fascioliasis by Enzyme-Linked Immunosorbent Assay (ELISA) Using Recombinant Cathepsin L Protease
por: Gonzales Santana, Bibiana, et al.
Publicado: (2013)

Schiff bases complexed with iron and their relation with the life cycle and infection by Schistosoma mansoni
por: da Silva, Juliana Virginio, et al.
Publicado: (2022)

Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection
por: Farnell, Edward J., et al.
Publicado: (2015)

Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target
por: Sanches, Rodrigo C. O., et al.
Publicado: (2021)

Systemic Cytokine and Chemokine Profiles in Individuals With Schistosoma mansoni Infection and Low Parasite Burden
por: Castro, Vanessa N., et al.
Publicado: (2018)

Schistosoma mansoni-Derived Lipids in Extracellular Vesicles: Potential Agonists for Eosinophillic Tissue Repair
por: Coakley, Gillian, et al.
Publicado: (2019)

Proteomic Analysis of Biomphalaria glabrata Hemocytes During in vitro Encapsulation of Schistosoma mansoni Sporocysts
por: Dinguirard, Nathalie, et al.
Publicado: (2018)

Baseline Gut Microbiota Composition Is Associated With Schistosoma mansoni Infection Burden in Rodent Models
por: Cortés, Alba, et al.
Publicado: (2020)

Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection
por: Zhang, Weidong, et al.
Publicado: (2020)

Previous History of American Tegumentary Leishmaniasis Alters Susceptibility and Immune Response Against Schistosoma mansoni Infection in Humans
por: Miranda, Guilherme Silva, et al.
Publicado: (2021)

Will Auranofin Become a Golden New Treatment Against COVID-19?
por: Sonzogni-Desautels, Karine, et al.
Publicado: (2021)

Myrrh and artesunate modulate some Th1 and Th2 cytokines secretion in Schistosoma mansoni infected mice
por: Elbakry, Kadry A., et al.
Publicado: (2016)

NLRP6 Plays an Important Role in Early Hepatic Immunopathology Caused by Schistosoma mansoni Infection
por: Sanches, Rodrigo C. O., et al.
Publicado: (2020)

CRISPR interference for sequence-specific regulation of fibroblast growth factor receptor A in Schistosoma mansoni
por: Du, Xiaofeng, et al.
Publicado: (2023)

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages
por: Arndts, Kathrin, et al.
Publicado: (2021)

Specific Antibodies and Arachidonic Acid Mediate the Protection Induced by the Schistosoma mansoni Cysteine Peptidase-Based Vaccine in Mice
por: Tallima, Hatem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9l1g2t85v415dhnqkn9b1lmv3p